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Abstract The structure of leptin receptor (OB-R) is highly 
homologous to that of gpl30, the common signal transducing 
receptor component for the interleukin-6 family of cytokines. 
Based on this structural similarity, we examined signaling 
processes initiated by OB-R in comparison with those by 
gpl30. Stimulation of either a long form of OB-R or gpl30 led 
to tyrosine phosphorylation of STAT3, whereas stimulation of 
the truncated form of OB-R that is predominantly expressed in 
dbldb mice failed to do so. Stimulation of the long form OB-R 
did not induce tyrosine phosphorylation of a Src homology 
domain 2 containing protein tyrosine phosphatase, SHP-2, while 
stimulation of gpl30 did. In contrast, activation of p42ERK2 is 
mediated by either the long form OB-R or gpl30. Two closely 
related molecules, OB-R and gpl30, thus appear to mediate 
overlapping but distinct signaling procedures. 
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1. Introduction 
Leptin (OB) is an adipose tissue-derived protein which ex-
erts weight-reducing effects in mice when administrated in 
vivo [1-4]. Recently, the receptor for this factor, OB-R, has 
been cloned and revealed to be a member of the class I cyto-
kine receptor family. OB-R shows the highest similarity to 
gpl30 that is a common signal transducer for interleukin 6 
(IL-6) family of cytokines [5,6]. 
The extracellular regions of OB-R, gpl30 and leukemia in-
hibitory factor receptor (LIFR) are closely related to each 
other and are composed of either six or eight fibronectin 
type III modules. They contain a set of four conserved cys-
teine residues and the tryptophan-serine-X-tryptophan-serine 
(X represents any amino acid) motif that are characteristic of 
the class I cytokine receptor family [5-7]. The cytoplasmic 
regions of OB-R, gpl30 and LIFR possess three conserved 
motifs, boxl, box2 and box3, in the membrane-proximal-to-
distal order [5-8]. In the case of gpl30, mutational analyses 
have indicated that the boxl motif is important for the asso-
ciation with Janus kinases (JAKs) and that the box2 motif 
plays a critical role, in concert with boxl, in mediating 
DNA synthesis [8-11]. Box3 contains a tyrosine-X-X-gluta-
mine (Y-X-X-Q) motif [12] which is proposed as a docking 
site for signal transducer and activator of transcription 3 
(STAT3) [13-16]. 
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IL-6, LIF, oncostatin M (OSM), ciliary neurotrophic factor 
(CNTF), IL-11 and cardiotrophin-1 (CT-1) are a subset of 
cytokines with structural and functional similarity [17,18]. 
All these IL-6 family cytokines signal through gpl30 protein 
dimerized by itself or with closely related LIFR [17-20]. For-
mation of gpl30 homodimer or gpl30/LIFR heterodimer trig-
gers the activation of JAKs, and activated JAKs phosphory-
late tyrosine residues in the cytoplasmic region of gpl30 and 
LIFR [10,11,19,20]. STAT3 is then recruited to the phos-
phorylated Y-X-X-Q motif through its Src-homology 2 
(SH2) domain and subsequently phosphorylated on tyrosine 
by activated JAKs [12,21]. Besides STAT3, STAT1 is tyro-
sine-phosphorylated when a high dose of IL-6 is used for 
gpl30 stimulation [14], although direct binding between 
ST ATI and gpl30 has not yet been demonstrated. SHP-2, a 
SH2 domain-containing protein tyrosine phosphatase [22,23], 
is also tyrosine-phosphorylated following stimulation of 
gpl30 [12,24]. After recruitment, SHP-2 undergoes tyrosine 
phosphorylation, which enables this molecule to bind with 
Grb2, an adapter molecules for activation of the Ras-ERK 
(extracellular signal-regulated protein kinases) cascade 
([25,26]; Narazaki, Nakashima and Taga, unpublished result). 
Indeed, gpl30 stimulation leads to activation of p42ERK2 [27]. 
In leptin-nonresponsive obesity mutant mice (dbldb mice), 
the short form of OB-R which lacks most of the cytoplasmic 
region but retains boxl is predominantly expressed. In such 
mice the long, complete form of OB-R is hardly expressed 
because of a guanine to thymine base substitution, which 
generates an aberrant splice donor site [28-30]. Recent reports 
showed that STAT1, 3, 5 and 6 are activated through the long 
form of OB-R but not through the short one and suggested 
that the lack of the long form of OB-R is responsible for the 
dbldb mouse phenotype [31,32]. 
Based on the similarity between OB-R and gpl30, it has 
been predicted that similar cytoplasmic molecules undergo 
modification and activation after stimulation of these two 
membrane receptors. Actually, similar kinds of STAT pro-
teins have been reported to be activated following OB-R 
and gpl30 stimulation [17,31,32]. In this study, we have ex-
amined leptin-induced modification or activation of SHP-2 
and p42ERK2 as well as STAT3. 
2. Materials and methods 
2.1. Materials 
Recombinant human IL-6 and soluble IL-6R (sIL-6R) were kindly 
provided by Dr. K. Yasukawa, Tosoh Corp., Kanagawa. Recombi-
nant human leptin expressed in E. coli was generously provided by 
Dr. F. de Sauvage, Genentech Inc., CA [33]. Anti-STAT3 antibody 
was generously provided by Dr. S. Akira, Hyogo College of Medicine, 
Hyogo. Anti-SHP-2 and p42ERK2 antibodies were obtained from San-
ta Cruz Biotechnologies (Santa Cruz, CA). Anti-phosphotyrosine 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(96)01430-5 
50 K. Nakashima et al.lFEBS Letters 401 (1997) 49-52 
(4G10) antibody was purchased from Upstate Biotechnology, Inc. 
(Lake Placid, NY). 
2.2. Plasmid construction 
Long and short forms of human OB-R cDNAs were obtained from 
Genentech Inc. [34,35]. These two OB-R cDNAs and STAT3 cDNA 
[15] were subcloned into mammalian expression vector pEF-BOS 
(generous gift from Dr. S. Nagata, Osaka University, Osaka). 
2.3. Transfection of COS7 cells and immunoblot analysis 
COS7 cells were maintained in Dulbecco's modified Eagle's medium 
containing 10% fetal calf serum and transfected with cDNAs by a 
DEAE-dextran method. After 2 days culture, the cells were starved 
for 4 h in medium without serum and then stimulated with cytokines 
for 10 min at 37°C. Cells were solubilized with Nonidet P-40 (NP-40) 
lysis buffer (0.5% NP-40/10 mM Tris-HCl, pH 7.6/150 mM NaCl/5 
mM EDTA/2 mM Na3V04/l mM phenylmethylsulfonyl fluoride/5 ug 
of aprotinin per ml), and then subjected to immunoprecipitation and 
immunoblotting. 
2.4. Binding assay 
Preparation of [125I]leptin and binding assay were carried out as 
described previously [36], The specific binding was calculated based 
on the counts obtained in the absence or presence of 200-fold excess 
unlabeled leptin. 
2.5. p42ERK2 kinase assay 
Anti-p42ERK2 immunoprecipitates were subjected to immune com-
plex kinase assay, using a consensus peptide (the ERK kinase assay 
system; Amersham, Buckinghamshire, UK) according to the manu-
facturer's protocol. 
3. Results 
3.1. The long form of OB-R is functional for STAT3 
modification 
As for cytokines that utilize gpl30 as a signal transducer, 
STAT3 is predominantly activated [15-17]. Hence, we tested 
whether STAT3 was tyrosine-phosphorylated in response to 
leptin stimulation. COS7 cells were transfected with expres-
sion constructs for STAT3 along with either a long or short 
form of OB-R. Transfected cells were therefore incubated with 
or without leptin, and cell lysates were subjected to immuno-
Fig. 1. The long form of OB-R is functional for tyrosine phosphor-
ylatin of STAT3. A: COS7 cells were transfected with cDNA for 
either the short or the long form of OB-R together with that for 
STAT3. Transfected cells were incubated with (+) or without (—) 50 
ng/ml of leptin and lysed. STAT3 was immunoprecipitated with 
anti-STAT3 antibody and subjected to Western blotting using anti-
phosphotyrosine (upper panel) or anti-STAT3 (lower panel) anti-
body. B: COS7 cells were untransfected (white column) or trans-
fected with either the short (shaded column) or the long (black col-
umn) form of OB-R with STAT3. The cells were incubated with 
[125I]leptin with or without a 200-fold excess of unlabeled leptin. 
The specific binding was calculated by subtracting the cell-associated 
counts obtained with the competitor from those without it. 
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Fig. 2. Tyrosine phosphorylation of SHP-2 is induced by stimula-
tion of gpl30 but not OB-R. COS7 cells were co-transfected with 
the long form of OB-R and STAT3, and treated with medium 
alone, 50 ng/ml each of leptin or a combination of IL-6 and sIL-
6R. Cell lysates were immunoprecipitated with anti-SHP-2 antibody 
followed by Western blotting using either anti-phosphotyrosine 
(upper panel) or anti-SHP-2 (lower panel) antibody. 
precipitation with anti-STAT3 antibody and subsequent im-
munoblotting with anti-phosphotyrosine antibody. As shown 
in Fig. 1A (upper panel), leptin induced STAT3 tyrosine phos-
phorylation through the long form of OB-R, but not through 
the short one which is predominantly expressed in dbldb mice. 
In each immunoprecipitate, comparable amounts of STAT3 
were present (Fig. 1A, lower panel). In each transfectant, 
comparable amounts of OB-R protein were present, as exam-
ined by binding of 125I-labeled leptin (Fig. IB). 
3.2. OB-R stimulation does not induce tyrosine phosphorylation 
of SHP-2 
It has been shown that gpl30 stimulation leads to tyrosine 
phosphorylation of SHP-2 [12,24]. We therefore assessed 
whether this occurs after stimulation of OB-R. COS7 cells 
were co-transfected with expression constructs for the long 
form of OB-R and STAT3, and treated with either medium 
alone, leptin or a complex of IL-6 and sIL-6R which is known 
to homodimerize gpl30 [19,37]. Endogenously expressed SHP-
2 was immunoprecipitated and immunoblotted with anti-
phosphotyrosine antibody. As shown in Fig. 2 (upper panel), 
tyrosine phosphorylation of SHP-2 was induced after stimula-
tion of gpl30 but not OB-R. The same filter was reprobed 
with anti-SHP-2 antibody to confirm that comparable 
amounts of SHP-2 were present in the immunoprecipitates 
(Fig. 2, lower panel). 
3.3. p42ERK2 is activated through OB-R stimulation 
We examined whether leptin induces p42ERK2 activation, 
which was known to occur by gpl30 stimulation. COS7 cell 
were transfected with expression constructs for the long form 
of OB-R and STAT3, and treated with either medium alone, 
leptin or a complex of IL-6 and sIL-6R. Cell lysates were then 
subjected to immunoprecipitation with anti-p42ERK2 antibody. 
The kinase activities associated with each immune complex 
were assayed using [y-32P]ATP and an ERK substrate peptide. 
As shown in Fig. 3, leptin stimulation through the long form 
of OB-R led to p42ERK2 activation. 
4. Discussion 
The long form of OB-R is highly homologous to gpl30 and 
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Fig. 3. p42ERK2 activation is induced following leptin stimulation. 
COS7 cells were transfected and treated as in Fig. 2. p42ERK2 was 
immunoprecipitated with anti-p42ERK2 antibody, and the immune 
complex was subjected to in vitro kinase assay, using a peptide sub-
strate (see Section 2). Columns show the mean ± range of two reac-
tions. 
contains a conserved box3 motif which has been suggested to 
be sufficient for recruitment of STAT3, in addition to box l 
and 2 motifs which are supposed to be important for activa-
tion of JAKs [5-12]. As demonstrated in this and previous 
papers, the long form of OB-R indeed induced tyrosine phos-
phorylation of STAT3 following leptin stimulation, while the 
short form of OB-R was not functional [31,32]. The dbldb 
mutant mice hardly express the long form of OB-R because 
of the mutat ion in an intron that leads to an aberrant splice 
choice. This mutat ion brings about the non-functional short 
form of OB-R lacking most of the cytoplasmic region. The 
deleted region includes box2 and box3 [28-30]. This deletion 
may account for the defect in reception of the leptin signal in 
dbldb mice. 
Both OB-R and gp l30 contain a Y-X-X-V motif (Y1 0 7 9-L-
G-V1082 for the former, Y759-S-T-V762 for the latter) which is 
suggested for SHP-2 binding [5,12,24]. In the case of gpl30 
stimulation, SHP-2 is actually recruited to gpl30 and subse-
quently tyrosine-phosphorylated ([12,24]; Fig. 2). However, 
this is not the case in leptin stimulation. Amino acid residues 
in, or around, the Y-X-X-V motif may influence the actual 
binding of SHP-2 to this motif. 
gp l30 stimulation induces p42 E R K 2 activation, and so does 
OB-R stimulation although the extent in the latter case seems 
smaller at least in COS7 cells (Fig. 3). There are reports in-
dicating that SHP-2 functions as an adapter for activation of 
the Ras -ERK cascade [25,26], and SHP-2 is indeed recruited 
to gpl30 and tyrosine-phosphorylated after gp l30 stimulation 
[12,24]. Grb2 then is proposed to bind to SHP-2, and is sug-
gested to switch the R a s - E R K cascade on ([25,26]; Narazaki , 
Nakashima and Taga, unpublished result). In contrast, OB-R 
stimulation leads to activation of p 4 2 E R i Q but does not induce 
tyrosine phosphorylation of SHP-2. The two closely related 
molecules gpl30 and OB-R appear to utilize distinct pathways 
to activate p42 E R K 2 . Taken together, gp l30 and OB-R appear 
to mediate overlapping but distinct cytoplasmic signals. It will 
be intriguing to investigate what actually accounts for the 
51 
divergence of the biological outcomes induced by OB-R and 
gpl30 . 
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